Diet, Health and Disease
Background
Probiotics are of growing interest within the scientific community, for consumers and for the food industry. They potentially provide functional health benefits. The interaction between the gut and intestinal flora and between resident and transient flora defines a new area in physiology, an understanding of which would shed light on the ‘cross talk’ between humans and microbes.
Health claims on specific probiotics are accepted in the USA, in Japan, and in some European countries. However, there is a need for comprehensive and harmonised guidelines on the assessment of the characteristics of probiotic as foods, biotherapeutic agents.
Objectives
The mission of the task force (TF) is to investigate how the physiological efficacy of probiotics can be assessed and to develop appropriate guidelines and recommendations to move the research field forward.
Therefore, the task force aims at advancing the understanding of scientific issues related to functional foods containing probiotics can impact the gut functions and health in general.
Impact
The work of the task force is contributing to the scientific understanding and underpinning of health claims regulations.
The evaluation of the range of activities will allow for fair comparison between different strains of probiotics and various products. Regulators will benefit from a guideline on the evaluation of the probiotics-related claims. Ultimately, the scientific substantiation of claimed benefits should increase consumers’ confidence in health claims.
A working relationship has been established with the IDF/ISO Joint Action Team (JAT) on Probiotics. The IDF/ISO JAT is represented as observer at the TF meetings in order to ensure coordination of work and communication between the two organisations.
Activities
Probiotics: Interplay with the intestine barrier function
The Task Force decided to look at the potential impact of probiotics on the gut microbiota, with an initial focus on the intestine barrier function. A brainstorming meeting with academic experts concluded that intestinal barrier impairment and microbiota changes can be influenced by different risks factors for Irritable Bowel Syndrome (acute infections, antibiotic usage, stress or other dietary factors), inducing a low grade inflammation that can contribute to different comorbidities and to changes in the gut physiology. However, a treatment with appropriate probiotic strains could be able to restore the intestinal barrier function and avoid the related cascade of stress.
An expert group is being set up to investigate how probiotics could impact the gut barrier function, differentiating indirect (modulation of the gut microbiota) and direct actions. As a first step, the expert group will look at intestinal barrier function, using both in vitro and animal data. As a second step, additional experts will be contacted to establish the impact of the intestinal barrier dysfunction at the human level.
The different outcomes of this activity will be published in a peer-reviewed journal and disseminated through presentations in scientific congresses and through our network with other probiotics associations.
Markers of Immuno-modulation for the General Population
It is known that immune markers are modulated within a certain range where it is still considered as safe. The lower and upper limits of this safe range are known for most of the immune markers from medical data. What is not always known is ‘how a certain ingredient can trigger a modulation’ and ‘how detrimental/beneficial this stimulation can be on the consumer’s health’. The Nutrition and Immunity Task Force together with the Probiotics Task Force commissioned an expert group to provide relevant markers and reference values in context of immuno-modulation induced by a dietary intervention within the healthy population.
A workshop will be held on 16 and 17 April 2012 with the objectives firstly to invite external experts to review the work done by the group. Secondly, it is aimed to propose scenarios for interpreting results observed during a trial. By this approach, the workshop contributes to a better understanding of the current limitations and insight in emerging opportunities for assessing immune modulation. It will thus promote further consensus on valuable and accessible markers for conducting intervention trials.
The outcome will be submitted to a peer-reviewed journal. The publication will summarise the markers reflecting normal function of the immune system which are indicative for immune modulation by nutrients/bio-active ingredients. It will also include proposals for interpreting variations in these markers.
Joint Concise Monograph on Probiotics and Prebiotics
Facing the recent published data on probiotics and prebiotics and their impact on health, the task force decided to join forces with the Prebiotics Task Force to commission a Concise Monograph. The aim is to provide the reader with a single document compiling both probiotic and prebiotic concepts that the public often mixes up. It would contain science-based answers to questions on modulating the gut microbiota by dietary intervention with probiotics and prebiotics in a balanced and complementary way.
Task Force Collaborators
Members 2012
Dr. Arthur Ouwehand - Chair - |
DuPont Nutrition Biosciences |
FI |
Dr. Annick Mercenier - Co-chair - |
Nestlé |
CH |
| |
|
|
Dr. Jean-Michel Antoine |
Danone |
FR |
Dr. Stephanie Courau |
Merck Consumer Healthcare |
FR |
Dr Diana Diofebi |
Dicofarm |
IT |
Dr. Udo Herz |
Mead Johnson Nutrition |
NL |
Dr. Irene Lenoir-Wijnkoop |
IDF - ILSI Liaison Officer |
FR |
Dr. Tami Mackle |
Pfizer Consumer Healthcare |
US |
Dr. Barbara Miller |
Procter & Gamble |
US |
Dr. Arjen Nauta |
Royal FrieslandCampina |
NL |
Dr. Tomoyuki Sako |
Yakult Europe |
NL |
Dr. Karl-Heinz Zirzow |
Cargill |
BE |
| |
|
|
Ms. Agnès Méheust |
ILSI Europe |
BE |
Ms. Toula Aslanidis |
ILSI Europe |
BE |
Probiotics: Interplay with the intestine barrier function
Prof. Jerry Wells - Chair - |
Wageningen University |
NL |
| |
|
|
Prof. Robert Brummer |
Örebro University |
SE |
Prof. Patrice Cani |
Université catholique de Louvain |
BE |
Dr. Jan Dekker |
Wageningen University |
NL |
Dr. Muriel Derrien |
Danone |
FR |
Prof. Willem de Vos |
Wageningen University |
NL |
Dr. Clara Garcia |
Nestlé |
CH |
| Prof. Thomas Mac Donald |
Centre for Immunology and Infectious Disease |
UK |
Dr. Arjen Nauta |
Royal FrieslandCampina |
NL |
Dr. Vassilia Theodorou |
National Institute of Agricultural Research - INRA |
FR |
Dr. Freddy Troost |
Maastricht University |
NL |
| |
|
|
Ms. Agnès Méheust |
ILSI Europe |
BE |
Expert Group on Markers of Immuno-modulation for the General Population
Prof. Ulrich Sack - Chair - |
Universität Leipzig |
DE |
Dr. Phoukham Phothirath - Co-chair- |
Nestlé |
CH |
| |
|
|
Dr. Ruud Albers |
NutriLeads BV |
NL |
Dr. Raphaëlle Bourdet-Sicard |
Danone |
FR |
Prof. Philip Calder |
University of Southampton |
UK |
| Dr. Murielle Cazaubiel |
Institut Mérieux |
FR |
Dr. Udo Herz |
Mead Johnson Nutrition |
NL |
Prof. Claude Lambert |
University HospitalCentre Hospitalier Universitaire St. Etienne |
FR |
Dr. Irene Lenoir-Wijnkoop |
IDF - ILSI Liaison Officer |
FR |
Prof. Jean-François Nicolas |
Centre Hospitalier Universitaire Lyon-Sud |
FR |
Dr. Arthur Ouwehand |
DuPont Nutrition Biosciences |
FI |
Dr. Tomoyuki Sako |
Yakult Europe |
NL |
Prof. Seppo Salminen |
University of Turku |
FI |
Dr. André Siemensma |
Royal FrieslandCampina |
NL |
Prof. Henk van Loveren |
National Institute of Public Health and the Environment – RIVM |
NL |
| |
|
|
Ms. Agnès Méheust |
ILSI Europe |
BE |
Ms. Marie Latulippe |
ILSI Europe |
BE |
Joint Concise Monograph on Probiotics and Prebiotics
Author |
|
|
Dr. Nino Binns |
Consultant |
IE |
Scientific Editors |
|
|
Prof. Glenn Gibson |
University of Reading |
UK |
Dr. Mary-Ellen Sanders |
International Scientific Association for Pro & Prebiotics |
US |
Scientific Reviewers |
|
|
Prof. Nathalie Delzenne |
Université Catholique de Louvain |
BE |
Prof. Lorenzo Morelli |
Catholic University of Piacenza |
IT |
Publication
To download the poster on Exploring the Interactions between Probiotics and Health, please click
here .